COG6

COG6 is a subunit of the Conserved Oligomeric Golgi (COG) complex that supports Golgi-based vesicle tethering and the maintenance of Golgi architecture (PMID:23057818). It binds a subset of Golgi SNAREs (STX5, STX6, GS27, SNAP29) through a SNARE-binding motif that is itself required for COG6 Golgi localization, such that loss of this motif both mislocalizes COG6 and abolishes its ability to perturb Golgi integrity (PMID:23057818). COG6 stabilizes its binding partners, including STX6, whose protein level drops sharply in COG6-deficient patient cells, and it is required for the stability of cooperating COG subunits and for normal retrograde intra-Golgi transport (PMID:23606727, PMID:41362306). Through these trafficking and tethering functions, COG6 sustains proper combined N- and O-glycosylation, and complete COG6 loss produces aberrant glycosylation as a functional consequence, defining a COG6-associated congenital disorder of glycosylation (PMID:41362306). COG6, as part of an intact COG complex, is also required for influenza A virus replication, contributing both to cell-surface sialic acid presentation and to protection of viral proteins from lysosome-dependent degradation, the latter occurring without a direct COG6–viral protein interaction (PMID:40910953).

1. 2012 High

   Established the molecular basis for how COG6 engages the membrane fusion machinery and why it is needed for Golgi structure, by identifying its SNARE partners and a localization-determining SNARE-binding motif.

   Evidence Yeast two-hybrid, reciprocal co-immunoprecipitation, and domain-deletion mutagenesis with overexpression/depletion phenotypic readouts

   PMID:23057818

   Open questions at the time

   • Does not define the stoichiometry or structural arrangement of COG6 within the assembled COG complex
   • Which SNARE interaction is rate-limiting for tethering versus localization is not resolved
2. 2013 Medium

   Showed that COG6 acts as a stabilizer of its partner STX6 in vivo, while revealing that glycosylation phenotypes of COG6 deficiency can be variable across patients.

   Evidence Protein-level analysis and transferrin isoelectrofocusing in COG6-deficient patient-derived cells

   PMID:23606727

   Open questions at the time

   • Single-lab patient study not independently replicated
   • Mechanism of STX6 destabilization (degradation pathway) not defined
   • Basis for the discordant transferrin glycosylation phenotype unexplained
3. 2025 Medium

   Demonstrated that complete COG6 loss destabilizes cooperating COG subunits, delays retrograde Golgi transport, and causes combined N- and O-glycosylation defects, linking COG6 trafficking function to disease-relevant glycosylation outcomes.

   Evidence Patient frameshift variant with subunit expression analysis, retrograde transport assay, and MALDI/HPLC-FLD/ESI-Orbitrap glycoprofiling

   PMID:41362306

   Open questions at the time

   • Single-lab study not independently replicated
   • Does not establish which specific glycosyltransferase mislocalization drives the glycan defects
4. 2025 Medium

   Extended COG6 function beyond glycosylation by showing an intact COG complex is required for influenza A virus replication, via sialic acid receptor presentation and protection of viral proteins from lysosomal degradation.

   Evidence Genome-wide CRISPR/Cas9 screen, COG subunit KO cell lines, surface sialic acid assays, lysosomal inhibitor rescue, and co-IP/pulldown interaction analysis

   PMID:40910953

   Open questions at the time

   • Not independently replicated
   • The indirect route by which COG6 loss diverts viral proteins to lysosomes is undefined
   • Whether the lysosomal proteostasis effect generalizes to host cargo is unknown

• How COG6 assembles within the full COG complex structurally, and the precise mechanism coupling its SNARE-tethering activity to selective cargo glycosylation and lysosomal routing, remain unresolved.
• No structural model of COG6 within the complex in the corpus
• No direct demonstration of which cargo glycosyltransferases depend on COG6 tethering
• Mechanism linking Golgi dysfunction to lysosomal degradation not elucidated